U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07184125) titled 'Effect of Midazolam as Premedication in Patients Undergoing Breast Conservation Study' on Sept. 13.
Brief Summary: Patient are randomized into 2 groups under computer registered numbers. Patient anxiety score is calculated through APAIS SCORE. Then one group is given Midazolam, and the other group is given normal saline and then after one day patients satisfaction is calculated through Lppsq scale.
Study Start Date: Aug. 30, 2024
Study Type: OBSERVATIONAL
Condition:
Pre Medication
Intervention:
DRUG: To measure anxiolysis, satisfaction level of patient after receiving Midazolam
Anxiety & satisfaction
Recruitment Status: COM...